Microparticles, vascular function and hypertension

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 2, 2010, Pages 177-180

  Boulanger, Chantal M ^a,b  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Endothelial microparticles; Prognostic value; Vascular dysfunction

Indexed keywords

ANGIOGENESIS; APOPTOSIS; ARTERY INJURY; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL ACTIVATION; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; INFLAMMATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THROMBOSIS;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; CELL-DERIVED MICROPARTICLES; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; PROGNOSIS;

EID: 76749103366     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32833640fd     Document Type: Review

References (41)

1. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM. Membrane micropar-ticles: two sides of the coin. Physiology (Bethesda) 2005; 20:22-27.
2. Chironi GN, Boulanger CM, Simon A, et al. Endothelial microparticles in diseases. Cell Tissue Res 2009; 335:143-151.
3. Curtis AM, Wilkinson PF, Gui M, et al. p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles. J Thromb Haemost 2009; 7:701-709.
4. Sapet C, Simoncini S, Loriod B, et al. Thrombin-induced endothelial micro-particle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 2006; 108:1868-1876.
5. Simoncini S, NjockMS, RobertS, et al. TRAIL/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation. Circ Res 2009; 104:943-951.
6. Peterson DB, Sander T, KaulS, et al. Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics 2008; 8:2430-2446.
7. Wang JM, Wang Y, Huang JY, et al. Reactive protein-induced endothelial microparticle generation in HUVECs is related to BH4-dependent NO formation. J Vasc Res 2007; 44:241-248.
8. Nolan S, Dixon R, Norman K, et al. Nitric oxide regulates neutrophil migration through microparticle formation. Am J Pathol 2008; 172:265-273.
9. Boulanger C, Amabile N, Guerin AP, et al. In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension 2007; 49:1-7.
10. Nomura S, Nakamura T, Cone J, et al. Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation. Cytometry 2000; 40:173-181.
11. Kuypers FA, de Jong K. The role of phosphatidylserine in recognition and removal of erythrocytes. Cell Mol Biol (Noisy-le-grand) 2004; 50:147-158.
12. Amabile N, Guerin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16:3381-3388.
13. Leroyer AS, Isobe H, Leseche G, et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007; 49:772-777.
14. Llorente-Cortes V, Otero-Vinas M, Camino-Lopez S, et al. Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells. Circulation 2004; 110:452-459.
15. Essayagh S, Brisset AC, Terrisse AD, et al. Microparticles from apoptotic vascular smooth muscle cells induce endothelial dysfunction, a phenomenon prevented by beta3-integrin antagonists. Thromb Haemost 2005; 94:853-858.
16. Stampfuss JJ, Censarek P, Fischer JW, et al. Rapid release of active tissue factor from human arterial smooth muscle cells under flow conditions. Arterioscler Thromb Vasc Biol 2006; 26:e34-e37.
17. Barry OP, FitzGerald GA. Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 1999; 82:794-800.
18. Mause SF, von Hundelshausen P, Zernecke A, et al. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005; 25:1512-1518.
19. Ray DM, Spinelli SL, Pollock SJ, et al. Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost 2008; 99:86-95.
20. Lok CA, Van Der Post JA, Sargent IL, et al. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy 2008; 27:344-360.
21. Brill A, Dashevsky O, Rivo J, et al. Platelet-derived microparticles induce angiogenesis and stimulate postischemic revascularization. Cardiovasc Res 2005; 67:30-38.
22. Pfister SL. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension 2004; 43:428-433.
23. Boulanger CM, Scoazec A, Ebrahimian T, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104:2649-2652.
24. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 2008; 173:1210-1219.
25. Diamant M,Tushuizen ME, SturkA, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34:392-401.
26. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 2004; 286:H1910-H1915.
27. Leroyer AS, Ebrahimian TG, Cochain C, et al. Microparticles from ischemic muscle promotes postnatal vasculogenesis. Circulation 2009; 119:2808-2817.
28. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006; 48:180-186.
29. Preston RA, Jy W, Jimenez JJ, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41:211-217.
30. Esposito K, Ciotola M, Giugliano F, et al. Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res 2007; 19:161-166.
31. Esposito K, Ciotola M, Schisano B, et al. Endothelial microparticles correlate with endothelial dysfunction in obese women. J Clin Endocrinol Metab 2006; 91:3676-3679.
32. Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101:841-843.
33. Koga H, Sugiyama S, Kugiyama K, et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005; 45:1622-1630.
34. Werner N, Wassmann S, Ahlers P, et al. Circulating CD31\+/annexin V\+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26:112.
35. Bernal-Mizrachi L, Ly W, Jimenez JJ, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145:962-970.
36. Amabile N, Heiss C, Real WM, et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008; 177:1268-1275.
37. Heiss C, Amabile N, Lee AC, et al. Brief second hand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol 2008; 51:1760-1771.
38. Chironi G, Simon A, Hugel B, et al. Circulating leukocyte-derived micropar-ticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol 2006; 26:2775-2780.
39. Amabile N, Heiss C, Chang V, et al. Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant 2009; 28:1081-1086.
40. Nozaki T, Sugiyama S, Koga H, et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol 2009; 54:601-608.
41. Amabile NA, Boulanger CM, Guerin A, et al. Circulating endothelial micro-particles: a new biomarker for prediction of subsequent death and cardiovascular events in end stage renal disease. Circulation 2009. American Heart Association Meeting in Orlando, Florida, 14-18 November 2009. [abstract 13384]